Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Save this article to read it later. Find this story in your account’s ‘Saved for Later’ section. We are still updating this guide. Click below to skip down to some of the biggest names in the list, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results